Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Clinics (Sao Paulo) ; 79: 100483, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39368400

RESUMO

INTRODUCTION: The role of IMP3, CDK4, MDM2 and ß-catenin proteins in Enchondroma and Central Chondrosarcoma is not totally understood. The aim of this study is to evaluate the immunoexpression of these proteins, associating histological grade, clinical data and prognosis to these tumors. METHODS: This is a retrospective-analytical study of 32 Enchondroma and 70 Central Chondrosarcoma. RESULTS: IMP3, CDK4, MDM2 and ß-catenin expression was observed in 22.82 %, 13.82 %, 17.17 % and in 8.8 % of cases, respectively. All Enchondromas positive for these immunomarkers were located in short tubular bones. The positivity for these antibodies is directly proportional to Chondrosarcoma's histological grade increase. No difference was found between Enchondroma and Chondrosarcoma, Grade 1 for IMP3, CDK4 and ß-catenin positivity. Significant metastasis outcome was observed for IMP3, CDK4, MDM2 and death for MDM2 expression. CONCLUSION: IMP3, CDK4, MDM2 and ß-catenin expression in Enchondromas of short bones phenotypically characterizes these tumors. Their expression has not proven to be useful either as diagnostic markers of these neoplasms or in distinguishing between Enchondroma and Chondrosarcoma, Grade 1. The significant immunoexpression of IMP3, CDK4 and MDM2 in metastatic Chondrosarcoma and the lower survival in those with positivity for MDM2 suggest a possible association of these proteins with tumor aggressiveness.


Assuntos
Biomarcadores Tumorais , Neoplasias Ósseas , Condroma , Condrossarcoma , Quinase 4 Dependente de Ciclina , Imuno-Histoquímica , Proteínas Proto-Oncogênicas c-mdm2 , beta Catenina , Humanos , Condrossarcoma/patologia , Condrossarcoma/metabolismo , Proteínas Proto-Oncogênicas c-mdm2/metabolismo , Proteínas Proto-Oncogênicas c-mdm2/análise , Masculino , Feminino , Neoplasias Ósseas/patologia , Neoplasias Ósseas/metabolismo , Pessoa de Meia-Idade , beta Catenina/análise , beta Catenina/metabolismo , Adulto , Estudos Retrospectivos , Biomarcadores Tumorais/análise , Prognóstico , Condroma/patologia , Quinase 4 Dependente de Ciclina/metabolismo , Quinase 4 Dependente de Ciclina/análise , Idoso , Adulto Jovem , Adolescente , Gradação de Tumores , Criança , Proteínas de Ligação a RNA
2.
Braz Dent J ; 21(1): 68-73, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20464324

RESUMO

Rhabdomyosarcoma is a malignant tumor occurring more frequently in the childhood. The purpose of this study was to analyze the clinicopathological and immunohistochemical features of rhabdomyosarcomas of the head and neck (RHNs). Twenty nine patients treated in a single institution were selected. The histological slides were reviewed and the tumors were classified. The immunohistochemical reactions were performed using antibodies against vimentin, desmin, myogenin, MyoD1, AE1/AE3, p53, PCNA, Ki67, C-erbB2, FAS and CDK4. The mean age was 14.3 years. The nonparameningeal site was affected in 16 cases (55.2%). Eleven cases (37.9%) affected parameningeal sites and 2 cases the orbit. The p53 was positive in 4 cases (13.8%), CDK4 in 10 cases (34.5%), C-erbB2 in 19 cases (70.4%), FAS in 9 cases (31%), PCNA in 28 cases (96.5%) and Ki67 in 16 cases (55.2%). The overall survival was 28.7% in 5 and 10 years, and p53 expression may be related with poor prognosis.


Assuntos
Neoplasias de Cabeça e Pescoço/epidemiologia , Rabdomiossarcoma/epidemiologia , Adolescente , Adulto , Fatores Etários , Idoso , Brasil/epidemiologia , Criança , Pré-Escolar , Quinase 4 Dependente de Ciclina/análise , Feminino , Humanos , Imuno-Histoquímica , Lactente , Antígeno Ki-67/análise , Masculino , Neoplasias Meníngeas/epidemiologia , Pessoa de Meia-Idade , Terapia Neoadjuvante , Estadiamento de Neoplasias , Neoplasias Orbitárias/epidemiologia , Antígeno Nuclear de Célula em Proliferação/análise , Receptor ErbB-2/análise , Estudos Retrospectivos , Fatores Sexuais , Taxa de Sobrevida , Proteína Supressora de Tumor p53/análise , Adulto Jovem , Receptor fas/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA